Market News

Procter And Gamble Co (PG) Holder Hermes Investment Management LTD Has Boosted Stake; As Celgene (CELG) Stock Value Declined, Shareholder Citizens & Northern Upped Its Stake

Celgene Corporation (NASDAQ:CELG) Logo

Hermes Investment Management Ltd increased its stake in Procter And Gamble Co (PG) by 0.67% based on its latest 2017Q4 regulatory filing with the SEC. Hermes Investment Management Ltd bought 6,487 shares as the company’s stock declined 15.56% with the market. The institutional investor held 978,491 shares of the package goods and cosmetics company at the end of 2017Q4, valued at $89.90M, up from 972,004 at the end of the previous reported quarter. Hermes Investment Management Ltd who had been investing in Procter And Gamble Co for a number of months, seems to be bullish on the $185.70 billion market cap company. The stock decreased 0.44% or $0.33 during the last trading session, reaching $73.85. About 3.26M shares traded. The Procter & Gamble Company (NYSE:PG) has declined 14.03% since May 24, 2017 and is downtrending. It has underperformed by 25.58% the S&P500.

Citizens & Northern Corp increased its stake in Celgene Corporation (CELG) by 23.92% based on its latest 2017Q4 regulatory filing with the SEC. Citizens & Northern Corp bought 3,157 shares as the company’s stock declined 19.30% with the market. The institutional investor held 16,354 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $1.71M, up from 13,197 at the end of the previous reported quarter. Citizens & Northern Corp who had been investing in Celgene Corporation for a number of months, seems to be bullish on the $57.83B market cap company. The stock increased 2.53% or $1.9632 during the last trading session, reaching $79.6232. About 5.16 million shares traded. Celgene Corporation (NASDAQ:CELG) has declined 31.28% since May 24, 2017 and is downtrending. It has underperformed by 42.83% the S&P500.

More notable recent Celgene Corporation (NASDAQ:CELG) news were published by: Finance.Yahoo.com which released: “5 Top Stock Trades for Tuesday Morning” on May 22, 2018, also Benzinga.com with their article: “Celgene Forges Oncology Partnership With Germany’s Evotec” published on May 22, 2018, Seekingalpha.com published: “Is Celgene’s Stock A Buy The Dip Opportunity?” on May 23, 2018. More interesting news about Celgene Corporation (NASDAQ:CELG) were released by: Finance.Yahoo.com and their article: “Celgene Corporation: How to Effectively Buy Into CELG Stock” published on May 22, 2018 as well as Seekingalpha.com‘s news article titled: “My 2 Cents On The Ozanimod Saga” with publication date: May 15, 2018.

Since February 8, 2018, it had 2 insider purchases, and 3 selling transactions for $3.48 million activity. Another trade for 18,500 shares valued at $1.77M was made by KAPLAN GILLA on Thursday, February 15. The insider LOUGHLIN JAMES J sold 9,250 shares worth $851,093. Shares for $1.26 million were sold by MARIO ERNEST.

Among 35 analysts covering Celgene Corporation (NASDAQ:CELG), 20 have Buy rating, 1 Sell and 14 Hold. Therefore 57% are positive. Celgene Corporation had 148 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was maintained by Stifel Nicolaus with “Buy” on Thursday, July 6. The stock of Celgene Corporation (NASDAQ:CELG) has “Outperform” rating given on Tuesday, April 19 by Credit Suisse. The company was maintained on Thursday, September 14 by Jefferies. Jefferies maintained Celgene Corporation (NASDAQ:CELG) on Friday, June 23 with “Buy” rating. The company was maintained on Thursday, October 5 by BMO Capital Markets. As per Friday, July 28, the company rating was maintained by Stifel Nicolaus. RBC Capital Markets downgraded the shares of CELG in report on Monday, May 7 to “Outperform” rating. The firm has “Buy” rating given on Tuesday, January 23 by Canaccord Genuity. Stifel Nicolaus initiated the stock with “Buy” rating in Friday, July 15 report. The firm has “Neutral” rating given on Wednesday, June 1 by BTIG Research.

Investors sentiment decreased to 0.83 in 2017 Q4. Its down 0.34, from 1.17 in 2017Q3. It worsened, as 156 investors sold CELG shares while 478 reduced holdings. 118 funds opened positions while 411 raised stakes. 561.38 million shares or 7.06% less from 603.99 million shares in 2017Q3 were reported. Calamos Advsr Ltd invested in 660,250 shares. Sigma Investment Counselors reported 28,224 shares. Davis has invested 2.44% in Celgene Corporation (NASDAQ:CELG). Advantus Cap Mgmt Incorporated accumulated 80,938 shares. Winslow Cap Mgmt Lc holds 436 shares or 0% of its portfolio. Moreover, Spc Fincl has 0.22% invested in Celgene Corporation (NASDAQ:CELG). Majedie Asset Mgmt Limited holds 37,994 shares or 0.33% of its portfolio. 7,271 were reported by Field Main National Bank & Trust. Gamco Inc Et Al holds 3,400 shares. Mai Mgmt reported 0.04% of its portfolio in Celgene Corporation (NASDAQ:CELG). Impax Asset Ltd Liability Corp holds 0.8% in Celgene Corporation (NASDAQ:CELG) or 134,085 shares. Amer Financial Grp Inc Inc reported 25,000 shares. Banque Pictet And Cie invested 1.59% in Celgene Corporation (NASDAQ:CELG). Arete Wealth Advsr Limited Liability Company holds 3,446 shares. Birchview Cap LP invested in 744,051 shares or 45.52% of the stock.

Among 25 analysts covering Proctor & Gamble (NYSE:PG), 10 have Buy rating, 1 Sell and 14 Hold. Therefore 40% are positive. Proctor & Gamble had 89 analyst reports since August 4, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Tuesday, January 16 by Goldman Sachs. The firm has “Equal-Weight” rating given on Tuesday, October 24 by Morgan Stanley. As per Friday, April 20, the company rating was downgraded by Argus Research. The rating was downgraded by TheStreet on Tuesday, August 4 to “Hold”. The stock of The Procter & Gamble Company (NYSE:PG) has “Neutral” rating given on Wednesday, January 24 by JP Morgan. Goldman Sachs downgraded the stock to “Sell” rating in Monday, January 9 report. The stock of The Procter & Gamble Company (NYSE:PG) earned “Hold” rating by Suntrust Robinson on Thursday, December 22. The company was maintained on Friday, July 31 by Deutsche Bank. The rating was maintained by RBC Capital Markets with “Hold” on Friday, June 30. The rating was maintained by Barclays Capital with “Equal-Weight” on Monday, March 21.

More notable recent The Procter & Gamble Company (NYSE:PG) news were published by: Seekingalpha.com which released: “Tracking Nelson Peltz’s Trian Fund Management Portfolio – Q1 2018 Update” on May 23, 2018, also Bizjournals.com with their article: “Former P&G executive to help guide marijuana firm” published on May 24, 2018, 247Wallst.com published: “Procter & Gamble Settling In as Worst-Performing Dow Stock of 2018” on April 28, 2018. More interesting news about The Procter & Gamble Company (NYSE:PG) were released by: 247Wallst.com and their article: “Procter & Gamble Now at 5 Weeks as Dow’s Worst Performing Stock” published on May 19, 2018 as well as Bizjournals.com‘s news article titled: “P&G using technology to peel back curtain on thousands of products on the shelf” with publication date: May 21, 2018.

Investors sentiment increased to 0.89 in 2017 Q4. Its up 0.07, from 0.82 in 2017Q3. It improved, as 64 investors sold PG shares while 740 reduced holdings. 118 funds opened positions while 594 raised stakes. 1.47 billion shares or 1.61% less from 1.50 billion shares in 2017Q3 were reported. The Texas-based Goodman has invested 0.01% in The Procter & Gamble Company (NYSE:PG). Parnassus Invs Ca reported 1.33% in The Procter & Gamble Company (NYSE:PG). Mairs Pwr Inc invested in 339,840 shares or 0.36% of the stock. First Commonwealth Corp Pa owns 39,421 shares for 3.83% of their portfolio. Torch Wealth Limited Liability stated it has 126,863 shares. Community Financial Bank Na has 0.68% invested in The Procter & Gamble Company (NYSE:PG). Hartford Mngmt has 7,845 shares for 0.35% of their portfolio. Confluence Wealth Mgmt Limited Liability owns 5,301 shares or 0.23% of their US portfolio. 2,432 were reported by Guardian Cap Lp. Portland Glob Advisors Limited Com has invested 0.6% in The Procter & Gamble Company (NYSE:PG). Blue Capital Incorporated accumulated 13,618 shares. Moreover, Calamos Wealth Mngmt Ltd has 0.97% invested in The Procter & Gamble Company (NYSE:PG) for 81,065 shares. Bush Odonnell Inv Advsrs Inc stated it has 65,600 shares. 26,684 were accumulated by Reilly Finance Ltd Liability. Coho Partners Limited invested 2.25% of its portfolio in The Procter & Gamble Company (NYSE:PG).

Since February 15, 2018, it had 0 buys, and 6 sales for $6.67 million activity. Posada Juan Fernando sold $739,189 worth of stock. 8,502 shares were sold by Pritchard Marc S., worth $668,179. Another trade for 37,776 shares valued at $3.07M was made by Schomburger Jeffrey K on Thursday, February 15. Bishop Steven D also sold $149,130 worth of The Procter & Gamble Company (NYSE:PG) on Wednesday, May 2.

Hermes Investment Management Ltd, which manages about $20.91B and $6.98B US Long portfolio, decreased its stake in Lkq Corp (NASDAQ:LKQ) by 56,708 shares to 1.15M shares, valued at $46.86 million in 2017Q4, according to the filing. It also reduced its holding in Bio Rad Labs Inc (NYSE:BIO) by 2,439 shares in the quarter, leaving it with 191,657 shares, and cut its stake in Cooper Cos Inc (NYSE:COO).

Celgene Corporation (NASDAQ:CELG) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *